The Latest Breaking News from asthma

Researchers revealed that a protein known as Piezo1 stops allergens from hyperactivating a kind of immune cell in the lungs. The work implies that activating Piezo1 could be a new therapeutic approach to lowering lung inflammation and treating allergic asthma. Read further on Dynamite News:

New Zealand's Asthma and Respiratory Foundation says a ban on disposable vapes is "a crucial step forward in combating the youth vaping epidemic".

Doctors told to ration liquid form of salbutamol, which plays vital role in treating asthma, emphysema and bronchitis

Public data from a network of state air monitors around the Houston Ship Channel is hard to interpret and is often inadequate, leaving Latino-majority neighborhoods like Cloverleaf unaware of whether the air they breathe is safe.

Teenager Harry Miller took his own life two years after being prescribed montelukast. His family say they were not made aware of the reported psychiatric side-effects of the drug

Campaigners call for more warnings on montelukast, after reports of night terrors, depression and other mental health events

Scientists have made a breakthrough discovery that could lead to a new treatment for severe asthma, a disease that has limited remedy options.

New York attorney general calls for stronger safety warning on popular asthma drug Singulair due to concerns about potential side effects.

The discontinuation of childhood asthma medication Flovent in the U.S. has led to challenges with the transition to the generic version, impacting parents,...

Xolair, a medication initially designed for asthma, has been approved for treating food allergies to prevent severe reactions.

The lack of medicine, food and water means thousands of people with asthma, kidney disease or diabetes are unable to treat or control their conditions